Herpes Zoster Vaccination: Controversies and Common Clinical Questions

Publisher： Karger

E-ISSN： 1423-0003|62|2|150-154

ISSN： 0304-324x

Source： Gerontology, Vol.62, Iss.2, 2016-0, pp. : 150-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic cutaneous lichenoid graft‐versus‐host disease at the area of herpes zoster infection and at a vaccination site

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 4, 2015-10 ,pp. : 1050-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications—authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 448-448

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 446-447

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hemorrhagic herpes zoster

By Huber Joakim   Hauswirth Alexander   Steininger Christoph  

Wiener klinische Wochenschrift, Vol. 119, Iss. 7-8, 2007-05 ,pp. : 217-217

Springer Publishing Company

Access to resources Recommend Favorite

Monoparesis secondary to herpes zoster

By Bilal S.  

Irish Journal of Medical Science, Vol. 180, Iss. 2, 2011-06 ,pp. : 603-604

Springer Publishing Company

Access to resources Recommend Favorite